insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS Read More
insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases Read More
insitro Hires AI and Machine Learning Visionary, Emily Fox, Ph.D., as Senior Vice President of AI/ML Read More
Leading Clinical Research Innovator, Amy Abernethy, M.D., Ph.D., Joins insitro Board of Directors Read More
Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM Read More
Machine learning across multiple imaging and biomarker modalities in the UK Biobank improves genetic discovery for liver fat accumulation Read More
Machine learning enabled prediction of digital biomarkers from whole slide histopathology images Read More
Deep learning analysis on images of iPSC-derived motor neurons carrying fALS-genetics reveals disease-relevant phenotypes Read More
Modelling Cellular Perturbations with the Sparse Additive Mechanism Shift Variational Autoencoder Read More
A pooled cell painting CRISPR screening platform enables de novo inference of gene function by self-supervised deep learning Read More
Learned phenotypic embeddings enable scalable imputation of high-content molecular data elucidating prognostic chromatin signatures Read More
insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug Hunter, as Chief Scientific Officer Read More
insitro and Genomics England Announce Partnership to Provide Multimodal Search Capabilities and Empower Data Exploration and Derivation of Novel Insights Read More
insitro Announces Leadership Team Expansion to Support Advancement of Machine Learning Enabled Drug Discovery and Development Efforts Read More
insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Read More
insitro Strengthens Machine Learning-Based Drug Discovery Capabilities with Acquisition of Haystack Sciences Read More
The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn’t going to stop them Read More
Gilead and insitro Announce Strategic Collaboration to Discover and Develop Novel Therapies for Nonalcoholic Steatohepatitis Read More
Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at insitro with some heavyweight backers Read More
